Importantly, miRNA193a-3p levels are downregulated in BC [19,31]; epigenetic alterations in miR193a-3p promotes HER2 positive BC aggressiveness [32]; and miR193a inhibits BC proliferation and metastasis [31,33]. This evidence concerns the gene ERBB2 and breast cancer.